Krystal Biotech, Inc.

KRYS

$345.82

Name : Krystal Biotech, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $10,235,869,184.00

EPSttm : 7.99

Krystal Biotech, Inc.

$345.82

0.25%

$0.86

KRYS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.18

Margin Of Safety %

-2

Put/Call OI Ratio

1.58

EPS Next Q Diff

0.45

EPS Last/This Y

0.79

EPS This/Next Y

1.45

Price

346.18

Target Price

392.11

Analyst Recom

1.23

Performance Q

-7.1

Upside

-19.2%

Beta

0.49

Ticker: KRYS

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	KRYS	351.55	0.84	0.71	7013
2026-08-31	KRYS	359.66	0.85	1.05	7044
2026-09-02	KRYS	368.23	0.84	0.13	7136
2026-09-03	KRYS	371.34	0.83	0.67	7179
2026-09-04	KRYS	358.03	0.84	6.35	7253
2026-09-08	KRYS	351.69	0.89	0.09	7509
2026-09-09	KRYS	348.26	0.88	0.08	7541
2026-09-10	KRYS	345.65	0.88	1.30	7583
2026-09-11	KRYS	347.2	0.88	0.59	7596
2026-09-14	KRYS	339.84	0.88	0.62	7624
2026-09-15	KRYS	336.64	0.88	0.03	7684
2026-09-16	KRYS	336.55	1.18	0.07	6715
2026-09-17	KRYS	339.65	1.18	0.18	6711
2026-09-18	KRYS	336.57	1.16	0.13	6762
2026-09-21	KRYS	333.79	1.66	0.94	4928
2026-09-22	KRYS	350.85	1.63	0.82	5232
2026-09-23	KRYS	341.61	1.59	0.64	5308
2026-09-24	KRYS	344.47	1.59	0.00	5317
2026-09-25	KRYS	346.15	1.58	0.42	5323
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	KRYS	351.70	-24.9	24.2	7.87
2026-08-31	KRYS	359.62	-24.9	34.4	7.87
2026-09-01	KRYS	363.84	-24.9	31.8	7.87
2026-09-02	KRYS	369.20	-24.9	134.0	7.87
2026-09-03	KRYS	371.48	-24.9	130.9	7.87
2026-09-04	KRYS	358.10	-24.9	116.1	7.87
2026-09-08	KRYS	351.39	-24.9	122.2	7.87
2026-09-09	KRYS	348.10	-24.9	125.1	7.87
2026-09-10	KRYS	345.61	-24.9	126.2	7.87
2026-09-11	KRYS	346.68	-24.9	130.0	7.87
2026-09-14	KRYS	339.93	-24.9	121.7	7.87
2026-09-15	KRYS	336.52	-24.9	125.2	7.87
2026-09-16	KRYS	336.52	-24.9	125.2	7.87
2026-09-17	KRYS	339.66	-24.9	131.9	7.87
2026-09-18	KRYS	336.40	-24.9	126.5	7.87
2026-09-21	KRYS	333.73	-24.9	125.7	7.87
2026-09-22	KRYS	351.13	-24.9	147.5	7.87
2026-09-23	KRYS	341.52	-24.9	119.1	7.87
2026-09-24	KRYS	344.94	-24.9	132.1	7.87
2026-09-25	KRYS	346.18	-24.9	130.6	7.87
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	KRYS	-3.63	3.69	12.37
2026-08-31	KRYS	-3.63	3.66	12.37
2026-09-01	KRYS	-3.63	3.66	12.37
2026-09-02	KRYS	-3.63	3.66	12.37
2026-09-03	KRYS	-3.63	3.66	12.37
2026-09-04	KRYS	-3.31	3.66	12.37
2026-09-08	KRYS	-3.31	3.75	12.37
2026-09-09	KRYS	-3.31	3.75	12.37
2026-09-10	KRYS	-3.31	3.75	12.37
2026-09-11	KRYS	-3.37	3.75	12.89
2026-09-14	KRYS	-3.37	3.75	12.89
2026-09-15	KRYS	-3.37	3.75	12.89
2026-09-16	KRYS	-3.37	3.75	12.89
2026-09-17	KRYS	-3.37	3.75	12.89
2026-09-18	KRYS	-3.37	3.75	12.89
2026-09-21	KRYS	-3.37	3.75	12.89
2026-09-23	KRYS	-3.37	3.75	12.89
2026-09-24	KRYS	-3.37	3.75	12.89
2026-09-25	KRYS	-3.37	3.75	12.18
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.79

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

2.24

Insider Transactions

-3.37

Institutional Transactions

3.75

Beta

0.49

Average Sales Estimate Current Quarter

130

Average Sales Estimate Next Quarter

144

Fair Value

340.87

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

9.5

Max Drawdown 5-Year %

-44.5

Target Price

392.11

P/E

43.34

Forward P/E

36.98

PEG

1.27

P/S

23.24

P/B

7.53

P/Free Cash Flow

39.71

EPS

7.98

Average EPS Est. Cur. Y

7.87

EPS Next Y. (Est.)

9.32

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

54.82

Relative Volume

0.5

Return on Equity vs Sector %

-8.5

Return on Equity vs Industry %

11.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

130.6

◆ KRYS Healthcare

$345.82

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

17/25

Volume

11/15

Valuation

10/20

TP/AR

4/10

Options

3/10

RSI

50.6

Range 1M

33.9%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

18/30

Estimates

5/20

Inst/Vol

5/15

Options

6/10

EPS Yr

11.2%

EPS NY

22.9%

52W%

83.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -0.6% upside

Quality

23/30

Valuation

3/30

Growth

17/25

Stability

8/10

LT Trend

3/5

Upside

-0.6%

Quality

MoS

-2%

KRYS — P/E HistoricalBiotechnology

Krystal Biotech, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 295

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

KRYS

Latest News

—

Caricamento notizie per KRYS…

stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today

news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance

stock history KRYS – Krystal Biotech, Inc. invest stock market

stock prices KRYS premarket after hours

ticker KRYS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KRYS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y